Clinical trial
The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?
NCT00282711 · Hartford Hospital, Other · Completed
Key facts
| NCT number | NCT00282711 |
|---|---|
| Title | The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN? |
| Official title | The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?"A Multi-Center, Prospective, Randomized Study to Establish the Optimal Method for Detection of CAD Risk in Women at an Intermediate-High Pre-Test Likelihood CAD" |
| Lead sponsor | Hartford Hospital, Other |
| Collaborators | GE Healthcare Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Coronary Artery Disease, Heart Disease, Coronary Arteriosclerosis, Cardiovascular Disease, Myocardial Ischemia |
| Enrollment | 824 |
| Start date | Jun 1, 2004 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2010 |
| First posted | Jan 27, 2006 |
| Last update posted | Aug 1, 2012 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: